Drug treatments affecting ACE2 in COVID-19 infection: a systematic review protocol.

Hajira Dambha-MillerAli AlbasriSam HodgsonChristopher WilcoxNazrul IslamShareen KhanPaul LittleSimon Griffin

Published in: BJGP open (2020)

This systematic review will identify drug therapies that may increase or decrease ACE2 expression. This might identify medications increasing risk of COVID-19 transmission, or as targets for intervention in mitigating transmission.

Keyphrases

systematic review
angiotensin converting enzyme
coronavirus disease
angiotensin ii
sars cov
poor prognosis
randomized controlled trial
meta analyses
adverse drug
drug induced
emergency department
binding protein
long non coding rna
respiratory syndrome coronavirus